ArticleThe Lancet. RheumatologyPublished
Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging study
Regional connection
Verified An author affiliation on the Europe PMC record names GSK. Affiliation source
- Institution
- GSK
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- The Lancet. Rheumatology
- Published
- Topic
- Clinical care
- PubMed ID
- 38279364
- Added to directory
- Source checked